IL6 and triple-negative breast carcinoma: –Noori MS, O’Brien JD, Champa ZJ, Deosarkar SP, Lanier OL, Qi C, et al. Phenylmethimazole and a thiazole derivative of phenylmethimazole inhibit IL-6 expression by triple negative breast cancer cells. Eur J Pharmacol. 2017 May 15;803:130–7.